ICCC Financial Facts
NET LOSS: 34.87KDiluted (in shares): 4.3M
See Full Income Statement
Deferred revenue: 33.86K
Total current liabilities: 1.05M
See Full Balance Sheet
ImmuCell Corp. (ICCC) Earnings
|
Expand Research on ICCC
| Next EPS Date | 8/19/26 | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | 0.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +52.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/19/26  |
Q226 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/14/26 | Q126 | $0.21 | N/A | N/A | $10.36M | N/A | N/A |  | | Details | |
| 3/4/26 | Q425 | -$0.31 | N/A | N/A | $7.63K | N/A | N/A | | | Details | |
| 11/13/25 | Q325 | -$0.02 | N/A | N/A | $5.56M | N/A | N/A | | | Details | |
| 8/14/25 | Q225 | $0.06 | N/A | N/A | N/A | N/A | N/A | | | Details | |
| 5/14/25 | Q125 | $0.16 | N/A | N/A | $8.07M | N/A | N/A | | | Details | |
| 2/25/25 | Q424 | $0.06 | N/A | N/A | $7.8M | N/A | N/A | | | Details | |
| 11/13/24 | Q324 | -$0.09 | N/A | N/A | $6.01M | N/A | N/A | | | Details |
